Richard A Lawhern and Pat Irving RN (2025) “The FDA is Talking When They Should Be Listening – Part 2: Review Article”, American Journal of Medical and Clinical Research & Reviews, 4(9), pp. 1–3. doi: 10.58372/2835-6276.1333.